Intravitreal Dexamethasone Implant as a Sustained Release Drug Delivery Device for the Treatment of Ocular Diseases: A Comprehensive Review of the Literature

• Prif Awduron: Claudio Iovino (Awdur), Rodolfo Mastropasqua (Awdur), Marco Lupidi (Awdur), Daniela Bacherini (Awdur), Marco Pellegrini (Awdur), Federico Bernabei (Awdur), Enrico Borrelli (Awdur), Riccardo Sacconi (Awdur), Adriano Carnevali (Awdur), Rossella D'Aloisio (Awdur), Alessio Cerquaglia (Awdur), Lucia Finocchio (Awdur), Andrea Govetto (Awdur), Stefano Erba (Awdur), Giacinto Triolo (Awdur), Antonio Di Zazzo (Awdur), Matteo Forlini (Awdur), Aldo Vagge (Awdur), Giuseppe Giannaccare (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: MDPI AG, 2020-07-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the mainstream route of drug administration to the posterior segment of the eye. The purpose of this review is to assess th...